CI is pairing top AI and biotech minds on its board (plus an advisory role for OpenAI's Fidji Simo) as it tests models on a Novo Nordisk drug.

Cellular Intelligence has licensed Novo Nordisk's cell therapy programme for Parkinson's disease, seven months after the Danish drugmaker wound down operations with the modality. Cellular Intelligence ...

Moderna co-founder Bob Langer and AI pioneer Yann LeCun join Cellular Intelligence's board as the startup builds a foundation model for cell ...

Cellular Intelligence has secured global rights to Novo Nordisk's Parkinson's program, a clinical-stage allogeneic cell therapy for Parkinson's disease with FDA Fast Track Designation. Cellular ...

Renowned University of Pennsylvania professor takes on expanded leadership role to advance the company's science and scale its closed-loop cell signaling platform. BOSTON, Aug. 12, 2026 /PRNewswire/ - ...

Cellular Intelligence has announced an agreement to acquire global rights to Novo Nordisk’s clinical-stage cell therapy program for Parkinson’s disease, with the intention of applying its proprietary ...

The year was 2021. Tech entrepreneur Micha Breakstone, PhD, had just sold the conversation intelligence platform, Chorus.ai, to ZoomInfo for $575 million and was eager for a new challenge. As an ...

Cells have always been the body’s original intelligence system – sensing, adapting, repairing, and communicating with remarkable precision. Today, artificial intelligence is beginning to mirror that ...

Cellular Intelligence Co-Founder & CEO Micha Breakstone joins Jon Fortt for a long-form conversation on decoding the language cells use to communicate — how a single fertilized cell becomes 35 ...

Agilent Technologies and the University of California San Diego agreed to collaborate to establish the Agilent Center of Excellence (CoE) in Cellular Intelligence, which is located at UC San Diego’s ...